CASI Pharmaceuticals, Inc. (CASI) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 93 transactions totaling $51.8M, demonstrating a bullish sentiment with $51.8M in net insider flow. The most recent transaction on Sep 8, 2022 involved a purchase of 33,300 shares valued at $142.5K.
No significant insider buying has been recorded for CASI in the recent period.
No significant insider selling has been recorded for CASI in the recent period.
Based on recent SEC filings, insider sentiment for CASI is bullish with an Insider Alignment Score of 100/100 and a net flow of $51.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CASI Pharmaceuticals, Inc. (CASI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading CASI stock, having executed 93 transactions in the past 90 days. The most active insider is Wei-wu He (Executive), who has made 36 transactions totaling $34.3M.
Get notified when executives and directors at CASI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 8, 2022 | Huang James | Executive | Purchase | 33,300 | $4.28 | $142.5K | |
| Sep 7, 2022 | Huang James | Executive | Purchase | 3,111 | $4.00 | $12.4K | |
| Sep 6, 2022 | Huang James | Executive | Purchase | 19,162 | $3.89 | $74.5K | |
| Sep 2, 2022 | Huang James | Executive | Purchase | 400 | $3.74 | $1.5K | |
| Sep 1, 2022 | Huang James | Executive | Purchase | 11,821 | $3.72 | $44.0K | |
| Aug 31, 2022 | Huang James | Executive | Purchase | 24,975 | $3.75 | $93.7K | |
| Aug 26, 2022 | Huang James | Executive | Purchase | 39,527 | $3.75 | $148.2K | |
| Aug 24, 2022 | Huang James | Executive | Purchase | 5,000 | $3.75 | $18.8K | |
| Aug 23, 2022 | Huang James | Executive | Purchase | 40,000 | $3.50 | $140.0K | |
| Aug 22, 2022 | Huang James | Executive | Purchase | 23,105 | $3.46 | $79.9K | |
| Aug 19, 2022 | Huang James | Executive | Purchase | 171,116 | $3.27 | $559.5K | Large |
| Jun 15, 2022 | He Wei-wu | Executive | Purchase | 50,000 | $3.18 | $159.0K | |
| Jun 14, 2022 | He Wei-wu | Executive | Purchase | 2,096 | $3.06 | $6.4K | |
| Jun 13, 2022 | He Wei-wu | Executive | Purchase | 36,058 | $2.97 | $107.1K | |
| Nov 18, 2021 | He Wei-wu | Executive | Purchase | 200,000 | $0.98 | $196.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 77 | $51.8M | 83.9% |
Other(J) | 3 | $5.1M | 8.2% |
Exercise (Options)(X) | 3 | $4.3M | 7.0% |
Disposition(D) | 2 | $323.5K | 0.5% |
Payment(F) | 3 | $128.9K | 0.2% |
Exercise(M) | 3 | $119.8K | 0.2% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at CASI Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 14 insiders making 93 transactions totaling $51.8M in purchases versus $0 in sales, the net buying activity of $51.8M signals strong executive confidence. Wei-wu He (Executive) leads the buying activity with $34.3M in transactions across all time.